Skip to main content
Log in

Intraocular pressure and endothelium cell counts after cataract surgery with chitosan and sodium hyaluronate (Healon GV): 3-Year follow-up results of a randomised clinical trial

  • Original Research
  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Introduction

The purpose of this study was to evaluate the long-term effects of chitosan 0.1% and sodium hyaluronate 1.4% (Healon GV®; Advanced Medical Optics, Santa Ana, CA, USA) on intraocular pressure (IOP) and endothelial cell loss.

Methods

This randomised study comprised 140 eyes of 140 patients with age-related cataracts undergoing phacoemulsification followed by posterior chamber intraocular lens (IOL) implantation; 70 received chitosan 0.1%, and 70 received sodium hyaluronate 1.4%. The IOP was measured with standard Goldman applanation tonometry pre-operatively and 1 day, 1 week, 1 month, 3 months, 1 year and 3 years postoperatively. Endothelial cell counts were performed pre-operatively and 1 week, 1 month, 3 months, 1 year and 3 years postoperatively using a Pro/Koester WFSCM contact endothelial microscope.

Results

There were no significant differences found in postoperative IOP levels among the chitosan and sodium hyaluronate groups (P>0.05). No significant differences were found in postoperative mean endothelial cell counts at all time points between the chitosan and sodium hyaluronate groups (P>0.05).

Conclusion

Chitosan has the same effects as sodium hyaluronate on IOP and endothelium cells counts after cataract surgery and IOL implantation, and therefore may be an alternative ophthalmic viscoelastic device.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kelman CD. Symposium: phacoemulsification. History of emulsification and aspiration of senile cataracts. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:OP5–OP13.

    PubMed  CAS  Google Scholar 

  2. Alpar JJ. Viscoelastic surgery. Ann Ophthalmol. 1987;19:350–353.

    PubMed  CAS  Google Scholar 

  3. Bourne WM, Liesegang TJ, Waller RR, Ilstrup DM. The effect of sodium hyaluronate on endothelial cell damage during extracapsular cataract extraction and posterior chamber lens implantation. Am J Ophthalmol. 1984;98:759–762.

    PubMed  CAS  Google Scholar 

  4. Musch DC, Meyer RF, Sugar A, Soong HK. Endothelial rejection following penetrating keratoplasty using Healon or BSS. Cornea. 1990;9:305–311.

    Article  PubMed  CAS  Google Scholar 

  5. Alpar JJ. Use of Healon in different cataract surgery techniques: endothelial cell count study. Ophthalmic Surg. 1987;18:529–531.

    PubMed  CAS  Google Scholar 

  6. Fry LL. Postoperative intraocular pressure rises: a comparison of Healon, Amvisc, and Viscoat. J Cataract Refract Surg. 1989;15:415–420.

    PubMed  CAS  Google Scholar 

  7. Liesegang TJ. Viscoelastic substances in ophthalmology. Surv Ophthalmol. 1990;34:268–293.

    Article  PubMed  CAS  Google Scholar 

  8. Li Y, Zhou Y, Hou C. Experimental study on intraocular use of chitosan. J Second Military Med Univ. 1997;18:455–457.

    Google Scholar 

  9. Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm. 1999;180:185–193.

    Article  PubMed  CAS  Google Scholar 

  10. Shigemasa Y, Minami S. Applications of chitin and chitosan for biomaterials. Biotechnol Genet Eng Rev. 1996;13:383–420.

    PubMed  CAS  Google Scholar 

  11. Sall KN, Kreter JK, Keates RH. The effect of chitosan on corneal wound healing. Ann Ophthalmol. 1987;19:31–33.

    Article  PubMed  CAS  Google Scholar 

  12. Felt O, Carrel A, Baehni P, Buri P, Gurny R. Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy. J Ocul Pharmacol Ther. 2000;16:261–270.

    Article  PubMed  CAS  Google Scholar 

  13. Alonso MJ, Sanchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol. 2003;55:1451–1463.

    Article  PubMed  CAS  Google Scholar 

  14. Enriquez de Salamanca A, Diebold Y, Calonge M, et al. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci. 2006;471:1416–1425.

    Google Scholar 

  15. Chen J, Li Q, Xu J, et al. Study on biocompatibility of complexes of collagenchitosan-sodium hyaluronate and cornea. Artif Organs. 2005;29:104–113.

    Article  PubMed  CAS  Google Scholar 

  16. Oztürk E, Ergün MA, Oztürk Z, et al. Chitosan-coated alginate membranes for cultivation of limbal epithelial cells to use in the restoration of damaged corneal surfaces. Int J Artif Organs. 2006;29:228–238.

    PubMed  Google Scholar 

  17. You L, Yunqiu Z, Chunlin H. The clinical effects of chitosan in cataract surgery and intraocular lens implantation. J Inj Occup Dis Eye Ophthalmic Surg. 1999;21:541–543.

    Google Scholar 

  18. Morgan RK, Skuta GL. Viscoelasticrelated glaucomas. Semin Ophthalmol. 1994;9:229–234.

    Article  PubMed  CAS  Google Scholar 

  19. Balazs EA, Freeman MI, Klöti R, Meyer-Schwickerath G, Regnault F, Sweeney DB. Hyaluronic acid and replacement of vitreous and aqueous humor. Mod Probl Ophthalmol. 1972;10:3–21.

    PubMed  CAS  Google Scholar 

  20. Dick HB, Krummenauer F, Augustin AJ, Pakula T, Pfeiffer N. Healon5 viscoadaptive formulation: comparison to Healon and Healon GV. J Cataract Refract Surg. 2001;27:320–326.

    Article  PubMed  CAS  Google Scholar 

  21. Tetz MR, Holzer MP, Lundberg K, Auffarth GU, Burk RO, Kruse FE. Clinical results of phacoemulsification with the use of Healon5 or Viscoat. J Cataract Refract Surg. 2001;27:416–420.

    Article  PubMed  CAS  Google Scholar 

  22. Schwenn O, Dick HB, Krummenauer F, Christmann S, Vogel A, Pfeiffer N. Healon5 versus Viscoat during cataract surgery: intraocular pressure, laser flare and corneal changes. Graefes Arch Clin Exp Ophthalmol. 2000;238:861–867.

    Article  PubMed  CAS  Google Scholar 

  23. Holzer MP, Tetz MR, Auffarth GU, Welt R, Volcker HE. Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery. J Cataract Refract Surg. 2001;27:213–218.

    Article  PubMed  CAS  Google Scholar 

  24. Arshinoff S. The physical properties of ophthalmic viscoelastics in cataract surgery. Ophthalmic Pract. 1991;9:81–86.

    Google Scholar 

  25. Hütz WW, Eckhardt HB, Kohnen T. Comparison of viscoelastic substances used in phacoemulsification. J Cataract Refract Surg. 1996;22:955–959.

    PubMed  Google Scholar 

  26. Dick B, Schwenn O, Pfeiffer N. Classification of viscoelastic substances for ophthalmologic surgery. Ophthalmologe. 1999;96:193–211.

    Article  PubMed  CAS  Google Scholar 

  27. Rizzuti AB. Cryosurgical cataract extraction under the operating microscope. Int Ophthalmol Clin. 1967;7:347–350.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chun-Lin Hou.

Additional information

You Li and Jin-Wei Cheng contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Cheng, JW., Wei, RL. et al. Intraocular pressure and endothelium cell counts after cataract surgery with chitosan and sodium hyaluronate (Healon GV): 3-Year follow-up results of a randomised clinical trial. Adv Therapy 25, 422–429 (2008). https://doi.org/10.1007/s12325-008-0059-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-008-0059-1

Keywords

Navigation